Tag: GlobeNewswire

MINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced 30-day clinical and hemodynamic outcomes for the Medium-size DurAVR^® Transcatheter Heart Valve (THV) in twenty-two severe aortic stenosis patients with medium aortic annuli (aortic annulus area 492 ± 38 mm²). The DurAVR THV demonstrated single digit mean gradients, large effective orifice areas (EOAs), no moderate or severe paravalvular leaks and no valve related mortality, with 100% freedom from moderate or severe prosthesis-patient mismatch^* (PPM) in a cohort of medium annuli patients from the EMBARK Study.

The 30-day Medium-size DurAVR THV results were presented by Azeem Latib, MD during the Emerging Concepts and Innovations in TAVR session at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Diego, California.

30-day Results Highlights

• DurAVR THV delivered a favorable hemodynamic profile with a large EOA of 2.64 ± 0.19 cm² (baseline 0.8 ± 0.2 cm²) and a single digit mean pressure gradient (MPG) of 6.17 ± 1.40 mmHg (baseline 45.5 ± 11.7 mmHg). 
• At 30-days, clinical safety outcomes were positive with no valve related mortality and no moderate or severe paravalvular leak (PVL).
• No moderate or severe prosthesis–patient mismatch was observed at 30 days.

“These are exceptional 30-day hemodynamics for medium annuli, with large effective orifice areas, single-digit gradients, and no moderate or severe PPM or paravalvular leak. That matters because prosthesis-patient mismatch is not just a small-annulus problem. A recent study in younger, lower-risk TAVR patients found PPM was associated with higher mortality and substantially more heart failure hospitalization at five years.¹ As TAVR moves to patients who will live with their valve for decades, this is the hemodynamic profile we designed DurAVR to deliver, and we look forward to PARADIGM confirming it in a randomized setting,” said Chris Meduri, M.D., Anteris Chief Medical Officer.

The DurAVR THV is being evaluated in the ongoing global PARADIGM pivotal trial (ClinicalTrials.gov ID NCT07194265), which is actively enrolling patients and will include use of the Medium-size DurAVR THV. This prospective, randomized controlled trial (RCT) is designed to evaluate the safety and effectiveness of DurAVR THV compared to commercially available transcatheter aortic valve replacements (TAVRs) in the treatment of severe aortic stenosis.

^{¹Suruga K, et al. Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2025;18(12).}

^{*Prosthesis‐patient mismatch (PPM) happens when a prosthetic valve, after being implanted, doesn’t have a large enough opening (EOA) to accommodate the patient’s blood flow needs, based on their body size. The result is higher than expected gradients. PPM affects a significant proportion of transcatheter aortic valve (TAVR) patients, particularly patients with a small aortic annulus and has been associated with impaired long-term survival following surgical aortic valve replacement (SAVR).}

^{**As defined in VARC-3}

About the PARADIGM Trial

The PARADIGM Trial is a prospective randomized controlled trial which will evaluate the safety and effectiveness of the DurAVR Transcatheter Heart Valve compared to commercially available transcatheter aortic valve replacements (TAVRs).

This head-to-head study will enrol approximately 1,000 patients in the ‘All Comers Randomized Cohort’ with 1:1 randomization of patients who will receive either the DurAVR THV or TAVR using commercially available and approved THVs. The PARADIGM Trial will assess non-inferiority on a primary composite endpoint of all-cause mortality, all stroke and cardiovascular hospitalization at one year post procedure.

For further information, please refer to ClinicalTrials.gov NCT07194265.

About Anteris

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.

Anteris’ lead product, the DurAVR THV, was designed in collaboration with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis – a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. DurAVR THV is made using a single piece of molded ADAPT^® tissue, Anteris’ patented anti-calcification tissue technology. ADAPT tissue, which is FDA-cleared, has been used clinically for over 10 years and distributed for use in over 55,000 patients worldwide. The DurAVR THV System is comprised of the DurAVR valve, the ADAPT tissue, and the balloon-expandable ComASUR^® Delivery System.

DurAVR THV is intended for INVESTIGATIONAL USE ONLY. Not available for commercial use or sale worldwide. CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.

Forward-Looking Statements

This announcement contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “budget,” “target,” “aim,” “strategy,” “plan,” “guidance,” “outlook,” “may,” “should,” “could,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described under “Risk Factors” in Anteris’ Annual Report on Form 10-K for the fiscal period ended December 31, 2025 that was filed with the Securities and Exchange Commission and ASX. Readers are cautioned not to put undue reliance on forward-looking statements, and except as required by law, Anteris does not assume any obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.   

For more information:
Global Investor Relations	Investor Relations (US)
investors@anteristech.com	mchatterjee@bplifescience.com
Debbie Ormsby	Malini Chatterjee, Ph.D.
Anteris Technologies Global Corp.	Blueprint Life Science Group
+61 1300 550 310 | +61 7 3152 3200	+1 917 330 4269

Website	www.anteristech.com
X	@AnterisTech
LinkedIn	https://www.linkedin.com/company/anteristech

Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions

NAVIGATE-PCI shows Heartflow PCI Navigator drove modifications to stent length and lesion prep compared to angiography alone

SAN FRANCISCO, Nov. 01, 2026 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced new landmark randomized clinical data presented at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, demonstrating computed tomography (CT)-guided percutaneous coronary intervention (PCI) matches gold-standard imaging outcomes with greater efficiency. These data are supported by registry insights on the procedural impact of Heartflow PCI Navigator.

In a late-breaking presentation simultaneously published in the New England Journal of Medicine (NEJM), the 1,105-patient P4 randomized clinical trial met its primary endpoint, demonstrating that CT-guided PCI planning was non-inferior to gold-standard intravascular ultrasound (IVUS) for one-year clinical outcomes. In the largest randomized trial of its kind, CT guidance achieved these matched results compared to IVUS while significantly improving procedural efficiency, delivering faster procedure times and utilizing lower contrast volume. Data from the NAVIGATE-PCI registry showed that interventional cardiologists altered their procedural strategy in approximately 70% of cases after incorporating 3D anatomic, plaque, and physiologic insights from Heartflow PCI Navigator compared to standard invasive coronary angiography alone.

“CT has already become routine for planning structural procedures like TAVR. The data presented at TCT show coronary intervention is ready to follow the same path with advanced pre-procedural imaging and Heartflow’s AI-powered analysis to deliver precision and efficiency,” said Campbell Rogers, M.D., F.A.C.C., Chief Medical Officer at Heartflow. “What we learned planning P4 cases across six separate tools shaped Heartflow PCI Navigator, which brings anatomy, plaque and physiology together in the first and only PCI planning tool backed by prospectively validated accuracy and randomized clinical trial data. Together, P4 and NAVIGATE-PCI support a paradigm shift in coronary intervention, bringing non-invasive CT-guided PCI planning into routine cath lab practice.”

P4 Trial: Validating CT-guided PCI Against IVUS with Greater Efficiency
Main Arena 4, November 1

The Heartflow-supported, investigator-initiated P4 trial directly evaluated the clinical efficacy of non-invasive CT-guided PCI planning against invasive IVUS guidance.

Enrolling 1,105 patients across 23 centers in the U.S., Europe, and Japan, P4 randomized stable CAD patients to either CT-guided PCI planning, including Heartflow FFR_CT Analysis and Heartflow Planner (an earlier version of Heartflow PCI Navigator), or intra-procedural IVUS guidance.

Key P4 trial one-year findings showed CT-guided PCI matched IVUS on outcomes while enabling a faster procedure and lower contrast use, including:

• CT-guided PCI matched IVUS for the primary endpoint of 12-month target-vessel failure (4.1% vs. 4.6%).
• CT-guided PCI had a 17-minute shorter median procedure time than IVUS (46 minutes vs. 63 minutes, a 27% reduction).
• Contrast volume was reduced by approximately 12% in the CT-guided arm (median 150 mL vs. 170 mL).
• CT-guided PCI more than doubled the use of advanced calcium modification (9.2% vs. 3.8%).

“Intravascular ultrasound is an established benchmark, but performing assessments inside the cath lab adds procedural time and requires expertise,” said Carlos Collet, M.D., Ph.D., principal investigator of the P4 trial and Director of Cardiovascular Imaging, Physiology and Translational Therapeutics at the Cardiovascular Research Foundation in New York. “P4 shows that non-invasive CT-guided PCI planning achieves comparable clinical outcomes with shorter procedure times and less contrast, enabling interventionalists to anticipate challenges, tailor their strategy, and enter the cath lab better prepared.”

NAVIGATE-PCI Registry: Optimizing Strategy Before Entering the Cath Lab
TCT AI Lab 3, November 1

NAVIGATE-PCI is a prospective, multi-center registry evaluating the real-world utility of Heartflow PCI Navigator, the first and only integrated, AI-driven PCI planning tool that gives interventional cardiologists a patient-specific 3D model detailing anatomy, plaque composition, and lesion-specific physiology, all aligned to streamline procedures with increased efficiency and clinical confidence. In the 203-patient cohort presented at TCT, investigators evaluated how access to integrated pre-procedural insights altered treatment strategies established immediately after invasive angiography.

Key NAVIGATE-PCI findings include:

• Treatment plans were modified in approximately 70% of patients after physicians reviewed Heartflow PCI Navigator prior to intervention, compared to angiography alone. The most frequent changes included stent length (41%) and lesion preparation technique (12%).
• Physicians rated their PCI Navigator plans with higher confidence than their angiography-based plans.

“Angiography only shows a two-dimensional silhouette, leaving critical blind spots around plaque burden, calcium and true vessel size,” said Ziad A. Ali, M.D., D.Phil., principal investigator of the NAVIGATE-PCI registry and Director of the DeMatteis Cardiovascular Institute at St. Francis Heart Center in New York. “Heartflow PCI Navigator fundamentally changes our approach, providing the comprehensive 3D and physiologic clarity needed to tailor treatment plans with greater confidence before entering the cath lab.”

The BRAVEHEART Registry: Revealing High CAD Burden in Firefighters to Accelerate Prevention
TCT 1488, November 3

Highlighting the impact of Heartflow’s technology across the entire continuum of care, investigators will also present data from the prospective BRAVEHEART registry. The study evaluated the use of AI-powered Heartflow Plaque Analysis and Heartflow FFR_CT Analysis to identify hidden coronary risk and encourage earlier preventive therapy in 96 asymptomatic firefighters with at least 10 years of occupational smoke exposure.

Key BRAVEHEART findings include:

• Subclinical coronary plaque was identified in 72% of asymptomatic firefighters (mean age 48.1 years), with 16% presenting with severe total plaque volume (>250 mm³).
• Willingness to initiate lipid-lowering medical therapy was reported by 68% of participants following review of their CCTA and Heartflow Analysis insights, while 93% committed to lifestyle modifications.

Experience Heartflow PCI Navigator at TCT 2026

TCT 2026 attendees are invited to visit Heartflow at exhibit booth #3819 for live demonstrations of Heartflow PCI Navigator. See the full schedule of other Heartflow programs, including a lunch symposium, hands-on training workshops, and more at event.heartflow.com/tct2026.

About Heartflow PCI Navigator

Heartflow expanded the Heartflow One platform with the addition of Heartflow PCI Navigator to support diagnosing, managing and guiding treatment for patients throughout the spectrum of CAD care. PCI Navigator is the only integrated, AI-driven percutaneous coronary intervention (PCI) planning tool that gives interventional cardiologists a patient-specific 3D model detailing anatomy, plaque composition, and lesion-specific physiology, all aligned to optimize potential stent placement. Heartflow introduced PCI Navigator to close the critical information gaps interventional cardiologists face before entering the cardiac catheterization lab.

About Heartflow Plaque Analysis with Plaque Staging

Heartflow Plaque Analysis is the only FDA-cleared, AI-powered plaque analysis tool with 95% agreement against the gold standard, intravascular ultrasound (IVUS), in a prospective, international trial.¹ Heartflow Plaque Staging builds on this foundation, categorizing plaque burden into clinical risk stages to guide actionable risk stratification.^2,3 The framework is validated in 23,000 patients with up to 16 years of follow-up, offering the reproducibility clinicians need for serial monitoring and individualized preventive care.

About Heartflow’s Technology and Research

Heartflow’s technology is redefining precision diagnostic testing and management for coronary artery disease (CAD) through clinically proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 750,000 patients worldwide.⁴ Key benefits include:

• Unmatched proprietary data pipeline: Built from the world’s largest database of more than 200 million annotated CTA images, Heartflow’s data foundation powers advanced AI models that deliver highly accurate, reproducible diagnostic insights across diverse patient populations.
• Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 200 studies assessing over 365,000 patients. Heartflow is the only AI platform prospectively validated against invasive gold standards and demonstrated through real-world evidence to improve patient outcomes.^3,5,6,7 Proven in real-world practice with reproducibility and accuracy, Heartflow’s coronary CTA image acceptance rates exceed 97%.
• Seamless clinical integration via upgraded workflow: Heartflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
• Quality system, global security and patient-data integrity compliance: Heartflow meets or exceeds leading international standards, including HITRUST r2, SOC 2 Type 2, MDSAP, ISO 13485, and ISO 27001.

About Heartflow, Inc.

Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures. Discover how we’re shaping the future of cardiovascular care at heartflow.com.

Media Contact
Elliot Levy
elevy@heartflow.com

Investor Contact
Nick Laudico
nlaudico@heartflow.com

_____________________________
¹ Ihdayhid A, et al. Radiol Cardiothorac Imaging. 2024. doi: 10.1148/ryct.230312 and internal bridging study with ICC correlation between first generation and second generation Plaque Analysis algorithm.
² Rinehart, et al. JACC Imaging. 2025.
³ Fairbairn et al. Coronary CT Angiography Plaque as a Predictor of Death, Cardiovascular Death and Myocardial Infarction. Presented at AHA 2025. (Real-world study with n=7,899 patients, higher TPV results in increased cardiovascular death and MI)h
⁴ Gulati M, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCAI Guideline for the Evaluation and Diagnosis of Chest Pain. Circulation 2021; 144:e368–e454.
⁵ Narula, et al. EHJ CVI 2024.
⁶ Danad, et al. JAMA Cardiol 2017.
⁷ Madsen KT, et al. ADVANCE-DK 7-year. Presented at TCT Scientific Sessions 2024. (n=900 patients determined a 2.5x increase in cardiovascular events or deaths at 7 years).

BEIJING, Nov. 01, 2026 (GLOBE NEWSWIRE) — During the 2026 Chery International User Summit, hosted by Chery Automobile (9973.HK) in Wuhu, FREELANDER presented its approach to in-car interaction and driver support to international guests, bringing together an AI Voice Assistant, digital cockpit displays and smartphone-based parking functions in FREELANDER 8. FREELANDER is a British Premium Intelligent All-Terrain Brand, jointly developed by JLR and Chery.

The FREELANDER Nightfall venue at the Hengli Hotel in Wuhu

More Natural In Car Conversations

Lucia Mao, CEO of FREELANDER International, introduced an AI Voice Assistant powered by a large language model and tailored for the brand. It is designed to support more natural conversations and a deeper understanding of the vehicle.

The assistant builds on an intelligent cockpit powered by the Qualcomm SA8295P Automotive-Grade Chip, which is standard across all trims. The interface uses immersive 3D visuals and four themes, while physical buttons remain for frequently used functions.

Lucia Mao introduces the AI Voice Assistant at FREELANDER Nightfall

Driving Information Across the Dashboard

The Surround View Gallery includes a 46.3-inch Mini LED Farside Integrated Display with 8K resolution. Spanning approximately 1.2 metres across the dashboard, it brings together seven core modules, including driving information, navigation and all-terrain status. A 15.6-inch centre display complements it, with an optional 17.3-inch ceiling-mounted entertainment display for rear passengers.

Parking and Driver Support

SIVP, or Super Intelligent Valet Parking, enables parking and vehicle recall through a smartphone app in supported scenarios. Availability is market-dependent and operation is subject to system operating conditions. The driver remains responsible at all times.

FREELANDER 8 also includes L2+ advanced driver assistance as standard, with more than 30 functions. These include Adaptive Cruise Control, Lane Centring Control, Automatic Emergency Braking and Around View Monitoring with Transparent Chassis, alongside automatic and remote parking. These systems support the driver and do not make the vehicle fully autonomous.

Technology in Focus

At FREELANDER Nightfall, guests were welcomed by Mornine, an embodied AI humanoid robot from Chery International’s AiMOGA brand. The programme paired technology presentations with driving experiences, giving international visitors an opportunity to explore the brand’s approach to vehicle interaction and everyday usability.

Media contact
Daniel Bao
freelander.international@mychery.com
https://www.cheryinternational.com/

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/d455ac27-193f-4728-82a9-f697762b63cf
https://www.globenewswire.com/NewsRoom/AttachmentNg/7d7a60d4-2277-4cdd-9c00-80f04760befc

BEIJING, Nov. 01, 2026 (GLOBE NEWSWIRE) — During the 2026 Chery International User Summit, hosted by Chery Automobile (9973.HK) in Wuhu, FREELANDER signed partnership agreements with EK Kanoo Group in Bahrain and Saud Bahwan Group in Oman, extending its Middle East network alongside its official UAE dealer partners, Al Tayer Motors and Premier Motors. FREELANDER is a British Premium Intelligent All-Terrain Brand, jointly developed by JLR and Chery.

Partnerships in Bahrain and Oman

The agreements were signed at FREELANDER Nightfall in Wuhu, where international guests also explored the five-seat version of FREELANDER 8 and heard about the brand’s design and technology direction.

Tim Zhang, General Manager of the Middle East Region at Chery International, signed on behalf of FREELANDER. Talal Fuad Ebrahim Kanoo, Managing Director of EK Kanoo Group, and Abdullah Mohammed Saud Bahwan, CEO of Saud Bahwan Group, represented the two partners. FREELANDER International CEO Lucia Mao witnessed the signing.

Brand executives and dealer representatives at FREELANDER Nightfall

Local Partners and Customer Trust

“For me, bringing FREELANDER to the world means more than entering new markets. It means earning the trust of our customers, every day,” said Mao. She emphasised the importance of strong local partners and dependable service.

British Design and Intelligent Technology

The international five-seat FREELANDER 8 offers a two-row alternative to the six-seat layout. Phil Simmons, EVP of the FREELANDER Design Hub and a member of the original Freelander design team, discussed the connection between the vehicle’s British design heritage and its contemporary form.

Mao also introduced an AI Voice Assistant powered by a large language model and tailored for FREELANDER. It is designed to enable more natural conversations and a deeper understanding of the vehicle.

The partnerships connect the brand’s international ambitions with local dealer networks, making regional representation and customer service central to its Middle East development.

Media contact
Daniel Bao
freelander.international@mychery.com
https://www.cheryinternational.com/

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/ddfa9486-83d9-4408-99f7-32ab62a1dac2

BEIJING, Nov. 01, 2026 (GLOBE NEWSWIRE) — International media, content creators and dealer partners shared their impressions of FREELANDER 8 after a test drive programme at the 2026 Chery International User Summit, hosted by Chery Automobile (9973.HK) in Wuhu, which combined rain-soaked tracks, challenging obstacles and paved roads. FREELANDER is a British Premium Intelligent All-Terrain Brand, jointly developed by JLR and Chery.

Driving in Changing Conditions

At Tuju Campground, participants drove through mud, S-bends, wavy roads, sand and gravel. The changing surfaces gave visitors a practical view of how the vehicle responds beyond a showroom setting.

“I think the driving experience is very good. The systems are working very well on the mud,” said a guest from Slovakia. A guest from Greece described the same course as feeling “like driving normally”.

FREELANDER 8 on the all-terrain course at Tuju Campground

Design and Driving Impressions

A guest from the Dominican Republic described the vehicle as “a combination of elegance, beauty and power for the off-road”, bringing design into a discussion otherwise centred on driving performance.

The i-ATS Intelligent All-Terrain System provides nine modes, including Smart Mode for changing surface conditions and Expert Mode for experienced drivers. The All-Terrain Dual Lock System supports traction, while dual-chamber air suspension allows additional ground clearance off road.

FREELANDER 8 negotiates a cross-axle section

From Obstacles to Open Roads

The obstacle course included steep inclines, water crossings and cross-axle sections. A separate paved course allowed participants to assess acceleration, braking, handling and ride comfort.

Together, the sessions gave overseas visitors a shared basis for assessing the vehicle across different driving environments, with their feedback addressing both its all-terrain character and its suitability for everyday use.

Media contact
Daniel Bao
freelander.international@mychery.com
https://www.cheryinternational.com/

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f095020c-eea1-4154-baa1-539e5c63bb9d
https://www.globenewswire.com/NewsRoom/AttachmentNg/c7494f3a-4687-4406-a16a-d0b1059cd0e7

BEIJING, Nov. 01, 2026 (GLOBE NEWSWIRE) — During the 2026 Chery International User Summit, hosted by Chery Automobile (9973.HK) in Wuhu, international guests tested FREELANDER 8 across mud, steep slopes and paved roads, offering first-hand feedback on the brand’s approach to combining all-terrain capability with everyday comfort. FREELANDER is a British Premium Intelligent All-Terrain Brand, jointly developed by JLR and Chery.

Testing in Rain and Mud

The programme brought together driving experiences at Tuju Campground, an obstacle course and a paved test course. Rain added to the challenge, giving participants an opportunity to assess the vehicle on slippery surfaces as well as on the road.

On a steep descent, a guest from Spain said their heart was “still pounding a little bit”, before adding: “But I trust the car.” A guest from Egypt welcomed the wet conditions as a demanding test of the slope.

A guest drives FREELANDER 8 at Tuju Campground

Comfort on the Road

On the paved course, a guest from the United Kingdom described FREELANDER 8 as “far more comfortable than I had expected.” A guest from Qatar said experiencing the car in person felt different from hearing about its capabilities.

The vehicle’s i-ATS Intelligent All-Terrain System offers nine terrain modes, while its All-Terrain Dual Lock System helps maintain traction. Dual-chamber air suspension with Continuously Controlled Damping supports ride comfort across changing surfaces.

Intelligent Parking

The programme also introduced SIVP, or Super Intelligent Valet Parking, for parking and vehicle recall through a smartphone app in supported scenarios. Availability is market-dependent and subject to system operating conditions; the driver remains responsible at all times.

The guests’ responses highlighted how confidence on difficult terrain and comfort on ordinary roads both shape perceptions of the brand.

Media contact
Daniel Bao
freelander.international@mychery.com
https://www.cheryinternational.com/

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/ddbb9207-a18e-4581-a6d2-7c8ccb5d35b0

• 34,246 vehicles were delivered in October 2026
• 334,547 vehicles were delivered year-to-date in 2026, increasing by 38.5% year-over-year
• Cumulative deliveries reached 1,332,139 as of October 31, 2026

SHANGHAI, Nov. 01, 2026 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its October 2026 delivery results.

The Company delivered 34,246 vehicles in October 2026. The deliveries consisted of 18,125 vehicles from NIO brand, 8,383 vehicles from ONVO brand, and 7,738 vehicles from FIREFLY brand. Cumulative deliveries reached 1,332,139 as of October 31, 2026.

On October 23, 2026, the NIO All-New ES8 reached its 160,000th delivery. From January to October 2026, the NIO All-New ES8 has ranked first in cumulative retail sales volume in both the large SUV segment and the RMB400,000-level vehicle segment in China. As the industry transitions from spec-led to brand-driven competition, sustained sales momentum for the NIO All-New ES8 further enhances recognition of the NIO brand in the premium market.

About NIO Inc.
NIO Inc. is a pioneer and a leading company in the global smart electric vehicle market. Founded in November 2014, NIO aspires to shape a sustainable and brighter future with the mission of “Blue Sky Coming”. NIO envisions itself as a user enterprise where innovative technology meets experience excellence. NIO designs, develops, manufactures and sells smart electric vehicles, driving innovations in next-generation core technologies. NIO distinguishes itself through continuous technological breakthroughs and innovations, exceptional products and services, and a community for shared growth. NIO provides premium smart electric vehicles under the NIO brand, premium smart electric vehicles for families through the ONVO brand, and high-end smart electric compact cars with the FIREFLY brand.

Safe Harbor Statement
This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. NIO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in announcements, circulars or other publications made on the websites of each of The Stock Exchange of Hong Kong Limited (the “SEHK”) and the Singapore Exchange Securities Trading Limited (the “SGX-ST”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about NIO’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NIO’s strategies; NIO’s future business development, financial condition and results of operations; NIO’s ability to develop and manufacture vehicles of sufficient quality and appeal to customers on schedule and on a large scale; its ability to ensure and expand manufacturing capacities including establishing and maintaining partnerships with third parties; its ability to provide convenient and comprehensive power solutions to its customers; the viability, growth potential and prospects of the battery swapping, BaaS, and NIO Assisted and Intelligent Driving and its subscription services; its ability to improve the technologies or develop alternative technologies in meeting evolving market demand and industry development; NIO’s ability to satisfy the mandated safety standards relating to motor vehicles; its ability to secure supply of raw materials or other components used in its vehicles; its ability to secure sufficient reservations and sales of its vehicles; its ability to control costs associated with its operations; its ability to build its current and future brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in NIO’s filings with the SEC and the announcements and filings on the websites of each of the SEHK and SGX-ST. All information provided in this press release is as of the date of this press release, and NIO does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please visit: http://ir.nio.com

Investor Relations
ir@nio.com

Media Relations
global.press@nio.com

• 34,246 vehicles were delivered in October 2026
• 334,547 vehicles were delivered year-to-date in 2026, increasing by 38.5% year-over-year
• Cumulative deliveries reached 1,332,139 as of October 31, 2026

SHANGHAI, Nov. 01, 2026 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its October 2026 delivery results.

The Company delivered 34,246 vehicles in October 2026. The deliveries consisted of 18,125 vehicles from NIO brand, 8,383 vehicles from ONVO brand, and 7,738 vehicles from FIREFLY brand. Cumulative deliveries reached 1,332,139 as of October 31, 2026.

On October 23, 2026, the NIO All-New ES8 reached its 160,000th delivery. From January to October 2026, the NIO All-New ES8 has ranked first in cumulative retail sales volume in both the large SUV segment and the RMB400,000-level vehicle segment in China. As the industry transitions from spec-led to brand-driven competition, sustained sales momentum for the NIO All-New ES8 further enhances recognition of the NIO brand in the premium market.

About NIO Inc.
NIO Inc. is a pioneer and a leading company in the global smart electric vehicle market. Founded in November 2014, NIO aspires to shape a sustainable and brighter future with the mission of “Blue Sky Coming”. NIO envisions itself as a user enterprise where innovative technology meets experience excellence. NIO designs, develops, manufactures and sells smart electric vehicles, driving innovations in next-generation core technologies. NIO distinguishes itself through continuous technological breakthroughs and innovations, exceptional products and services, and a community for shared growth. NIO provides premium smart electric vehicles under the NIO brand, premium smart electric vehicles for families through the ONVO brand, and high-end smart electric compact cars with the FIREFLY brand.

Safe Harbor Statement
This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. NIO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in announcements, circulars or other publications made on the websites of each of The Stock Exchange of Hong Kong Limited (the “SEHK”) and the Singapore Exchange Securities Trading Limited (the “SGX-ST”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about NIO’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NIO’s strategies; NIO’s future business development, financial condition and results of operations; NIO’s ability to develop and manufacture vehicles of sufficient quality and appeal to customers on schedule and on a large scale; its ability to ensure and expand manufacturing capacities including establishing and maintaining partnerships with third parties; its ability to provide convenient and comprehensive power solutions to its customers; the viability, growth potential and prospects of the battery swapping, BaaS, and NIO Assisted and Intelligent Driving and its subscription services; its ability to improve the technologies or develop alternative technologies in meeting evolving market demand and industry development; NIO’s ability to satisfy the mandated safety standards relating to motor vehicles; its ability to secure supply of raw materials or other components used in its vehicles; its ability to secure sufficient reservations and sales of its vehicles; its ability to control costs associated with its operations; its ability to build its current and future brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in NIO’s filings with the SEC and the announcements and filings on the websites of each of the SEHK and SGX-ST. All information provided in this press release is as of the date of this press release, and NIO does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please visit: http://ir.nio.com

Investor Relations
ir@nio.com

Media Relations
global.press@nio.com

BEIJING, China, Nov. 01, 2026 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 29,025 vehicles in October 2026. As of October 31, 2026, Li Auto’s cumulative deliveries reached 1,862,676.

In October, Li Auto delivered over 3,000 units of the new Li MEGA. The Company also introduced its proprietary Lianshan Battery and Lianshan Motor, along with the Lianshan Battery Warranty Program. The 2026 Li i6, launched on October 28, is equipped with the Lianshan Battery, the MACH M100 chip, and more than 20 additional upgrades in intelligence and configuration, enhancing its range, assisted driving capabilities, and riding experience. In November, Li Auto will begin rolling out OTA 9.2, featuring the upgraded MACH VLA 2.5 and multiple refined cockpit Agent features.

As of October 31, 2026, the Company had 481 retail stores in 159 cities, 527 servicing centers and Li Auto-authorized servicing shops operating in 217 cities. The Company also had 4,206 super charging stations in operation equipped with 23,163 charging stalls in China.

About Li Auto Inc.

Li Auto Inc. is a leader in China’s new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric vehicles. Its mission is: Be Proactive, Change the World. Through innovations in product, technology, and business model, the Company provides families with safe, convenient, and comfortable products and services. Li Auto is a pioneer in successfully commercializing extended-range electric vehicles in China. While firmly advancing along this technological route, it builds platforms for battery electric vehicles in parallel. The Company leverages technology to create value for users. It concentrates its in-house development efforts on proprietary range extension systems, innovative electric vehicle technologies, and smart vehicle solutions. The Company started volume production in November 2019. It offers high-tech flagship family MPVs, Li L series extended-range electric SUVs, and Li i series battery electric SUVs. The Company will continue to expand its product lineup to target a broader user base.

For more information, please visit: https://ir.lixiang.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets,” “likely to,” “challenges,” and similar statements. Li Auto may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “HKEX”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Li Auto’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Li Auto’s strategies, future business development, and financial condition and results of operations; Li Auto’s limited operating history; risks associated with extended-range electric vehicles and high-power charging battery electric vehicles; Li Auto’s ability to develop, manufacture, and deliver vehicles of high quality and appeal to customers; Li Auto’s ability to generate positive cash flow and profits; product defects or any other failure of vehicles to perform as expected; Li Auto’s ability to compete successfully; Li Auto’s ability to build its brand and withstand negative publicity; cancellation of orders for Li Auto’s vehicles; Li Auto’s ability to develop new vehicles; and changes in consumer demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Li Auto’s filings with the SEC and the HKEX. All information provided in this press release is as of the date of this press release, and Li Auto does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Li Auto Inc.
Investor Relations
Email: ir@lixiang.com

Christensen Advisory
Tel: +86-10-5900-1548
Email: Li@christensencomms.com

BEIJING, China, Nov. 01, 2026 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 29,025 vehicles in October 2026. As of October 31, 2026, Li Auto’s cumulative deliveries reached 1,862,676.

In October, Li Auto delivered over 3,000 units of the new Li MEGA. The Company also introduced its proprietary Lianshan Battery and Lianshan Motor, along with the Lianshan Battery Warranty Program. The 2026 Li i6, launched on October 28, is equipped with the Lianshan Battery, the MACH M100 chip, and more than 20 additional upgrades in intelligence and configuration, enhancing its range, assisted driving capabilities, and riding experience. In November, Li Auto will begin rolling out OTA 9.2, featuring the upgraded MACH VLA 2.5 and multiple refined cockpit Agent features.

As of October 31, 2026, the Company had 481 retail stores in 159 cities, 527 servicing centers and Li Auto-authorized servicing shops operating in 217 cities. The Company also had 4,206 super charging stations in operation equipped with 23,163 charging stalls in China.

About Li Auto Inc.

Li Auto Inc. is a leader in China’s new energy vehicle market. The Company designs, develops, manufactures, and sells premium smart electric vehicles. Its mission is: Be Proactive, Change the World. Through innovations in product, technology, and business model, the Company provides families with safe, convenient, and comfortable products and services. Li Auto is a pioneer in successfully commercializing extended-range electric vehicles in China. While firmly advancing along this technological route, it builds platforms for battery electric vehicles in parallel. The Company leverages technology to create value for users. It concentrates its in-house development efforts on proprietary range extension systems, innovative electric vehicle technologies, and smart vehicle solutions. The Company started volume production in November 2019. It offers high-tech flagship family MPVs, Li L series extended-range electric SUVs, and Li i series battery electric SUVs. The Company will continue to expand its product lineup to target a broader user base.

For more information, please visit: https://ir.lixiang.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “targets,” “likely to,” “challenges,” and similar statements. Li Auto may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”) and The Stock Exchange of Hong Kong Limited (the “HKEX”), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Li Auto’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Li Auto’s strategies, future business development, and financial condition and results of operations; Li Auto’s limited operating history; risks associated with extended-range electric vehicles and high-power charging battery electric vehicles; Li Auto’s ability to develop, manufacture, and deliver vehicles of high quality and appeal to customers; Li Auto’s ability to generate positive cash flow and profits; product defects or any other failure of vehicles to perform as expected; Li Auto’s ability to compete successfully; Li Auto’s ability to build its brand and withstand negative publicity; cancellation of orders for Li Auto’s vehicles; Li Auto’s ability to develop new vehicles; and changes in consumer demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Li Auto’s filings with the SEC and the HKEX. All information provided in this press release is as of the date of this press release, and Li Auto does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Li Auto Inc.
Investor Relations
Email: ir@lixiang.com

Christensen Advisory
Tel: +86-10-5900-1548
Email: Li@christensencomms.com